TW202016110A - Jak激酶家族之小分子抑制劑 - Google Patents

Jak激酶家族之小分子抑制劑 Download PDF

Info

Publication number
TW202016110A
TW202016110A TW108120432A TW108120432A TW202016110A TW 202016110 A TW202016110 A TW 202016110A TW 108120432 A TW108120432 A TW 108120432A TW 108120432 A TW108120432 A TW 108120432A TW 202016110 A TW202016110 A TW 202016110A
Authority
TW
Taiwan
Prior art keywords
compound
diffraction pattern
suspension
jak
solvent
Prior art date
Application number
TW108120432A
Other languages
English (en)
Chinese (zh)
Inventor
菲利浦 費南德斯
保羅 克拉祖克
馬克 蒂奇諾
Original Assignee
比利時商健生藥品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=67766195&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW202016110(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 比利時商健生藥品公司 filed Critical 比利時商健生藥品公司
Publication of TW202016110A publication Critical patent/TW202016110A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW108120432A 2018-06-15 2019-06-13 Jak激酶家族之小分子抑制劑 TW202016110A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862685737P 2018-06-15 2018-06-15
US62/685,737 2018-06-15
US201962846290P 2019-05-10 2019-05-10
US62/846,290 2019-05-10

Publications (1)

Publication Number Publication Date
TW202016110A true TW202016110A (zh) 2020-05-01

Family

ID=67766195

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108120432A TW202016110A (zh) 2018-06-15 2019-06-13 Jak激酶家族之小分子抑制劑

Country Status (23)

Country Link
US (3) US20200017498A1 (cg-RX-API-DMAC7.html)
EP (1) EP3807277A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021528391A (cg-RX-API-DMAC7.html)
KR (1) KR102768284B1 (cg-RX-API-DMAC7.html)
CN (1) CN112313233A (cg-RX-API-DMAC7.html)
AU (1) AU2019286641A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020024744A2 (cg-RX-API-DMAC7.html)
CA (1) CA3101438A1 (cg-RX-API-DMAC7.html)
CL (1) CL2020003227A1 (cg-RX-API-DMAC7.html)
CO (1) CO2020015396A2 (cg-RX-API-DMAC7.html)
CR (1) CR20200603A (cg-RX-API-DMAC7.html)
EC (1) ECSP20080817A (cg-RX-API-DMAC7.html)
IL (1) IL279314A (cg-RX-API-DMAC7.html)
JO (1) JOP20200311A1 (cg-RX-API-DMAC7.html)
MA (1) MA52900A (cg-RX-API-DMAC7.html)
MX (1) MX2020013688A (cg-RX-API-DMAC7.html)
NI (1) NI202000100A (cg-RX-API-DMAC7.html)
PE (1) PE20212113A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551984A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202011691PA (cg-RX-API-DMAC7.html)
TW (1) TW202016110A (cg-RX-API-DMAC7.html)
UY (1) UY38262A (cg-RX-API-DMAC7.html)
WO (1) WO2019239387A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US12390451B2 (en) 2021-03-11 2025-08-19 Janssen Pharmaceutica Nv Small molecule inhibitor of the JAK family of kinases
CN113292561A (zh) * 2021-05-22 2021-08-24 中国药科大学 一种二吡咯并吡啶结构的化合物、制备方法和医药用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080747A (en) 1999-03-05 2000-06-27 Hughes Institute JAK-3 inhibitors for treating allergic disorders
AR023561A1 (es) 1999-04-23 2002-09-04 Smithkline Beecham Corp Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP2005529933A (ja) 2002-05-31 2005-10-06 シェーリング コーポレイション キサンチンホスホジエステラーゼvインヒビター多形体
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
US7737279B2 (en) 2005-05-10 2010-06-15 Bristol-Myers Squibb Company 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
WO2007005462A1 (en) 2005-07-01 2007-01-11 Wyeth Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same
JP5071374B2 (ja) 2005-07-14 2012-11-14 アステラス製薬株式会社 ヘテロ環ヤヌスキナーゼ3阻害剤
CN102127078A (zh) 2005-07-14 2011-07-20 安斯泰来制药株式会社 Janus激酶3的杂环类抑制剂
AU2009257602B2 (en) 2008-06-10 2015-10-08 Abbvie Inc. Novel tricyclic compounds
SI2473510T1 (sl) 2009-09-03 2014-10-30 Bristol-Myers Squibb Company Jak2 inhibitorji in njihova uporaba za zdravljenje mieloproliferativnih bolezni in raka
JP2013512282A (ja) * 2009-12-01 2013-04-11 アボット・ラボラトリーズ 新規三環式化合物
EP4782062A2 (en) 2009-12-01 2026-07-29 AbbVie Inc. Novel tricyclic compounds
CN102712640A (zh) 2010-01-12 2012-10-03 弗·哈夫曼-拉罗切有限公司 三环杂环化合物、其组合物和应用方法
CA2789186A1 (en) 2010-02-10 2011-08-18 Genon Biotechnologies Oy Dual activity kinase domains and uses thereof
WO2013007765A1 (en) * 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
GB201212081D0 (en) 2012-07-06 2012-08-22 Kalvista Pharmaceuticals Ltd New polymorph
JP6248948B2 (ja) 2013-02-08 2017-12-20 日産化学工業株式会社 3環性ピロロピリジン化合物及びjak阻害剤
EP2924026A1 (en) 2014-03-28 2015-09-30 Novartis Tiergesundheit AG Aminosulfonylmethylcyclohexanes as JAK inhibitors
JP6561984B2 (ja) 2014-05-14 2019-08-21 日産化学株式会社 3環性化合物及びjak阻害剤
ES2924698T3 (es) 2015-05-28 2022-10-10 Theravance Biopharma R&D Ip Llc Proceso e intermedios para la preparación de compuestos de naftiridina como inhibidores de quinasa JAK
WO2017079639A1 (en) 2015-11-04 2017-05-11 Mayo Foundation For Medical Education And Research Methods and materials for treating autoimmune conditions
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
UA125824C2 (uk) 2016-10-24 2022-06-15 Астразенека Аб 6,7,8,9-ТЕТРАГІДРО-3H-ПІРАЗОЛО[4,3-f]ІЗОХІНОЛІНОВІ ПОХІДНІ, ЗАСТОСОВНІ В ЛІКУВАННІ РАКУ
US20200077658A1 (en) 2016-12-16 2020-03-12 Basf Se Pesticidal Compounds
JOP20190144A1 (ar) * 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
WO2018109607A1 (en) 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
JP6793836B2 (ja) 2016-12-16 2020-12-02 イーライ リリー アンド カンパニー 変異体idh1およびidh2阻害剤としての7−フェニルエチルアミノ−4h−ピリミド[4,5−d][1,3]オキサジン−2−オン化合物
MX2019006047A (es) 2016-12-16 2019-10-02 Nestle Sa Oligosacaridos para generacion de sabor.
CN110167938B (zh) 2017-01-11 2024-06-14 阿基利昂有限公司 作为Janus激酶抑制剂的新的氨基-咪唑并吡啶衍生物及其医药用途
CR20190379A (es) 2017-01-30 2019-10-21 Astrazeneca Ab Moduladores del receptor de estrógeno
MX2019012431A (es) 2017-04-21 2020-08-03 Ikena Oncology Inc Inhibidores del receptor de hidrocarburos de arilo (ahr) de indol y usos de los mismos.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
US20200338051A1 (en) 2019-04-24 2020-10-29 Janssen Pharmaceutica Nv Non-clinical liquid formulations of pan-jak inhibitor

Also Published As

Publication number Publication date
JP2021528391A (ja) 2021-10-21
US20200165250A1 (en) 2020-05-28
KR20210021342A (ko) 2021-02-25
EP3807277A1 (en) 2021-04-21
PH12020551984A1 (en) 2021-08-02
BR112020024744A2 (pt) 2021-03-23
PE20212113A1 (es) 2021-11-04
UY38262A (es) 2019-12-31
CR20200603A (es) 2021-01-20
WO2019239387A1 (en) 2019-12-19
US11787807B2 (en) 2023-10-17
US11066406B2 (en) 2021-07-20
AU2019286641A1 (en) 2020-12-10
MX2020013688A (es) 2021-02-26
JOP20200311A1 (ar) 2020-11-30
ECSP20080817A (es) 2021-01-29
CA3101438A1 (en) 2019-12-19
MA52900A (fr) 2021-04-21
US20210340144A1 (en) 2021-11-04
US20200017498A1 (en) 2020-01-16
KR102768284B1 (ko) 2025-02-13
CO2020015396A2 (es) 2021-03-08
CL2020003227A1 (es) 2021-05-14
NI202000100A (es) 2021-06-30
CN112313233A (zh) 2021-02-02
SG11202011691PA (en) 2020-12-30
IL279314A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
TWI777997B (zh) Jak激酶家族之小分子抑制劑
TWI726094B (zh) 作為jak激酶抑制劑之嘧啶化合物
TW202446369A (zh) 葡萄糖依賴性促胰島素多肽受體拮抗劑及其用途
WO2023109883A1 (zh) 一类芳杂环取代的化合物及其制备方法和用途
UA126394C2 (uk) Похідні бензоксазолу як імуномодулятори
WO2021115457A1 (zh) 吡唑并[1,5-a]吡啶类化合物及其制备方法和应用
JP2020502141A (ja) Jakファミリーのキナーゼの阻害剤としてのイミダゾピロロピリジン
KR102768284B1 (ko) Jak 패밀리의 키나제의 소분자 억제제
TW202200575A (zh) 一種免疫抑制劑、其製備方法和應用
CN106661032A (zh) 治疗或预防糖尿病、肥胖症和炎性肠病的1,3‑取代的2‑氨基吲哚衍生物及类似物
TW200304817A (en) Chemical compounds
US20220056026A1 (en) Crystalline forms of a selective c-kit kinase inhibitor
JPWO2019189555A1 (ja) 複素環化合物
CN116075513A (zh) Nek7激酶的抑制剂
US20150306070A1 (en) Use of maleimide derivatives for preventing and treating leukemia
UA121315C2 (uk) Макроциклічні інгібітори кінази rip2
WO2023036252A1 (zh) 吡咯并嘧啶类或吡咯并吡啶类衍生物及其医药用途
CN107428682B (zh) 酰胺类衍生物、其制备方法及其在医药上的用途
HK40008834B (en) Small molecule inhibitors of the jak family of kinases
HK40130027A (en) Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof
CN117820340A (zh) Atr抑制剂及其用途
HK40084227B (en) Pyridazinyl thiazolecarboxamide compound
CN120569387A (zh) Par2的小分子调节剂及其用途
AU2022206999A9 (en) Bridged heterocyclyl-substituted pyrimidine compounds, preparation method and medical use thereof
HK40059656B (zh) 哒嗪基噻唑甲酰胺类化合物